GO:0005923 bicellular tight junction: Components, Assembly and Research Methods, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0005923 bicellular tight junction (zonula occludens) is an occluding cell-cell junction that forms a branching network of sealing strands encircling the apical end of epithelial cells.
Tight junctions act as both barriers and multifunctional molecular gates that regulate paracellular transport and cell signaling.
Core components include claudins, occludin, JAMs, and scaffolding proteins such as ZO-1, which assemble into strand networks.
Tight junction dysfunction is linked to intestinal barrier defects, biliary diseases, and cancer progression.
Nutrients such as butyrate can enhance barrier function by promoting tight junction assembly via AMPK activation.
Targeted modulation of tight junctions is an emerging therapeutic strategy for drug delivery and disease intervention.

Description

The bicellular tight junction (GO:0005923), also known as the zonula occludens, is a specialized cell-cell junction that seals the paracellular space between adjacent epithelial cells. It is composed of a branching network of sealing strands that completely encircle the apical end of each cell in an epithelial sheet, with the outer leaflets of the interacting plasma membranes tightly apposed where sealing strands are present. This structure is critical for maintaining tissue barriers and regulating the passage of ions, solutes, and water across epithelial layers. Researchers study tight junctions to understand epithelial barrier function, paracellular transport, and the pathogenesis of diseases ranging from inflammatory bowel disease to cancer. The tight junction is not a static barrier but a dynamic, multifunctional molecular gate that responds to physiological and pathological signals. Recent advances have revealed heterogeneity in the expression of bicellular and tricellular tight junction components along the human intestinal tract, highlighting the complexity of barrier regulation.

bicellular tight junction At A Glance

GO ID GO:0005923
GO term bicellular tight junction
Ontology cellular_component
Synonym zonula occludens
Definition An occluding cell-cell junction composed of a branching network of sealing strands that completely encircles the apical end of each cell in an epithelial sheet; the outer leaflets of the two interacting plasma membranes are tightly apposed where sealing strands are present.
Major function Barrier formation and paracellular transport regulation
Key components Claudins, occludin, JAMs, ZO-1, and other scaffolding proteins
Associated diseases Biliary diseases, intestinal barrier dysfunction, cancer

What Is GO:0005923?

The bicellular tight junction is an occluding cell-cell junction composed of a branching network of sealing strands that completely encircles the apical end of each cell in an epithelial sheet. The outer leaflets of the two interacting plasma membranes are tightly apposed where sealing strands are present. Each sealing strand is composed of a long row of transmembrane adhesion proteins embedded in each of the two interacting plasma membranes.

Why Is bicellular tight junction Important in Cell Biology?

The bicellular tight junction is essential for maintaining tissue homeostasis by forming a selective barrier that controls the paracellular movement of ions, solutes, and water. Its dysfunction is implicated in a wide range of human diseases, including inflammatory bowel disease, biliary disorders, and cancer. Understanding tight junction biology is therefore critical for developing therapies that modulate barrier function, enhance drug delivery, and treat epithelial pathologies.
Maintains epithelial barrier integrity and tissue homeostasis.
Regulates paracellular transport of ions, solutes, and water.
Dysfunction contributes to inflammatory bowel disease and other intestinal disorders.
Implicated in biliary diseases such as cholestasis and gallstone formation.
Altered expression is associated with cancer progression and metastasis.
Serves as a target for drug delivery via tight junction modulators.
Nutrients like butyrate can enhance barrier function through AMPK activation.
Heterogeneous expression of tight junction components along the intestinal tract affects regional barrier properties.
Tight junctions are dynamic structures that respond to physiological and pathological signals.
Research on tight junctions informs the development of therapies for barrier-related diseases.

What Happens During bicellular tight junction?

Assembly of sealing strands
In simple terms: Cells build a network of protein strands that seal the space between them.
Tight junction assembly begins with the polymerization of claudins and other transmembrane proteins into sealing strands at the apical-lateral membrane boundary. These strands form a branching network that completely encircles the apical end of each cell, creating a physical barrier between adjacent cells. The assembly process is regulated by scaffolding proteins such as ZO-1, which link the transmembrane proteins to the actin cytoskeleton.
Barrier formation and paracellular transport
In simple terms: The sealed strands control what can pass between cells.
Once assembled, the tight junction acts as a selective barrier that regulates the paracellular flux of ions, solutes, and water. The barrier properties are determined by the specific claudin composition, which varies among tissues and along the intestinal tract. This selectivity is crucial for maintaining tissue-specific microenvironments and overall homeostasis.
Dynamic regulation and signaling
In simple terms: The tight junction is not static; it can open and close in response to signals.
Tight junctions are dynamic structures that undergo continuous remodeling in response to physiological and pathological stimuli. They also serve as signaling platforms that regulate cell proliferation, differentiation, and polarity. For example, butyrate enhances intestinal barrier function by facilitating tight junction assembly via AMPK activation in Caco-2 cell monolayers.
Heterogeneity along the intestinal tract
In simple terms: Different parts of the gut have different tight junction compositions.
Recent studies have revealed heterogeneous gene expression of bicellular and tricellular tight junction-sealing components along the human intestinal tract. This regional heterogeneity contributes to segment-specific barrier properties and may influence susceptibility to diseases.

Key Genes Involved in GO:0005923 bicellular tight junction

The following genes encode key proteins that constitute or regulate the bicellular tight junction.
GeneMajor RoleResearch Relevance
CLDN1Claudin family transmembrane protein; forms sealing strandsBarrier function, cancer, inflammation
CLDN2Claudin family transmembrane protein; regulates paracellular cation fluxIntestinal barrier, IBD
CLDN3Claudin family transmembrane proteinEpithelial barrier, cancer
CLDN4Claudin family transmembrane proteinBarrier function, cancer
CLDN5Claudin family transmembrane proteinEndothelial barrier, blood-brain barrier
OCLNOccludin; transmembrane protein contributing to sealing strandsBarrier regulation, inflammation
JAM-AJunctional adhesion molecule; regulates tight junction assemblyBarrier function, leukocyte migration
ZO-1Scaffolding protein linking transmembrane proteins to actinTight junction assembly, signaling
ZO-2Scaffolding proteinTight junction assembly
ZO-3Scaffolding proteinTight junction assembly
CingulinCytoplasmic plaque proteinTight junction regulation
Myosin IXBActin-based motor proteinTight junction dynamics
RhoASmall GTPase regulating actin cytoskeletonTight junction assembly and permeability
AMPKEnergy sensor kinasePromotes tight junction assembly in response to butyrate
TricellulinTricellular tight junction proteinBarrier function at tricellular contacts
MARVELD3Tricellular tight junction proteinBarrier function
ILDR1Tricellular tight junction proteinBarrier function

How Is bicellular tight junction Regulated?

Tight junction assembly and function are regulated by multiple signaling pathways. AMP-activated protein kinase (AMPK) activation by butyrate promotes tight junction assembly in intestinal epithelial cells. RhoA and other small GTPases regulate the actin cytoskeleton to modulate tight junction dynamics. Additionally, tight junction proteins themselves can act as signaling molecules that influence cell proliferation and differentiation. The expression of tight junction components is also regulated at the transcriptional level, with heterogeneous patterns along the intestinal tract.

bicellular tight junction and Human Disease

GeneDisease / BiologyPotential Experimental Model
CLDN1Cancer, inflammationKnockout and overexpression in epithelial cell lines
CLDN2Inflammatory bowel diseaseIntestinal organoids and knockout mice
OCLNBarrier dysfunctionCaco-2 cell monolayers with knockout
ZO-1Epithelial barrier defectsKnockout and knock-in in MDCK cells
JAM-AInflammation, cancerKnockout mice and cell lines
Tight junctions in biliary diseases
Tight junction proteins play critical roles in biliary physiology, and their dysfunction is associated with biliary diseases such as cholestasis and gallstone formation. Alterations in tight junction composition can lead to impaired bile secretion and liver injury.
Tight junctions and intestinal barrier dysfunction
Disruption of tight junctions in the intestinal epithelium contributes to increased permeability and inflammation, as seen in inflammatory bowel disease. Nutrients and microbial metabolites can modulate tight junction assembly and barrier function.
Tight junctions in cancer
Altered expression and localization of tight junction proteins are frequently observed in cancer, where they can influence tumor progression, invasion, and metastasis. Tight junction proteins are considered potential therapeutic targets and biomarkers in oncology.

From bicellular tight junction-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of CLDN1 affect barrier function?CLDN1 knockout in Caco-2 cells
How does a point mutation in OCLN alter tight junction assembly?OCLN point-mutation knock-in in epithelial cells
Can overexpression of ZO-1 rescue barrier defects?ZO-1 overexpression in knockout cells
What is the role of JAM-A in leukocyte migration?JAM-A knockout mice
How does butyrate regulate tight junction assembly?AMPK knockout Caco-2 cells treated with butyrate
What is the effect of tricellulin knockdown on barrier?Tricellulin knockout in intestinal epithelial cells

How to Study the bicellular tight junction Process

MethodWhat It MeasuresTypical Application
TEERBarrier integrityAssessment of tight junction function in cell monolayers
Paracellular flux assayPermeability to solutesQuantification of barrier leakiness
ImmunofluorescenceProtein localizationVisualization of tight junction structure
Electron microscopyUltrastructure of sealing strandsDetailed analysis of tight junction morphology
qRT-PCRmRNA expression levelsProfiling of tight junction genes
RNA-seqTranscriptome-wide expressionHeterogeneity of tight junction components
Co-immunoprecipitationProtein-protein interactionsMapping of tight junction protein complexes
Proximity ligation assayIn situ protein interactionsDetection of close proximity between proteins
Measuring barrier function
Transepithelial electrical resistance (TEER) and paracellular flux assays are standard methods to assess tight junction barrier function in epithelial cell monolayers. These techniques quantify the integrity of the tight junction seal and are widely used in studies of barrier regulation.
Imaging tight junction structure
Immunofluorescence and electron microscopy are used to visualize tight junction morphology and the localization of specific proteins such as claudins and ZO-1. These methods reveal the branching network of sealing strands and changes in protein distribution under different conditions.
Gene expression analysis
Quantitative RT-PCR and RNA-seq are employed to measure the expression levels of tight junction genes in tissues and cell models. These approaches have revealed heterogeneous expression patterns along the intestinal tract.
Protein interaction studies
Co-immunoprecipitation and proximity ligation assays are used to investigate interactions among tight junction proteins and their binding partners. Such studies help define the molecular architecture of the tight junction plaque.

How CRISPR Can Be Used to Study GO:0005923 bicellular tight junction

Knockout

CRISPR knockout of tight junction genes such as CLDN1, OCLN, or ZO-1 in epithelial cell lines allows researchers to assess their specific contributions to barrier function and paracellular transport. Knockout models have been instrumental in defining the roles of individual claudins in selective permeability.

Point Mutation

Introducing point mutations into tight junction genes can mimic disease-associated variants and reveal how specific amino acid changes affect protein function and junction assembly. For example, point mutations in claudins can alter ion selectivity and barrier properties.

Knock-in

Knock-in of tagged versions of tight junction proteins, such as GFP-tagged ZO-1, enables live-cell imaging and proteomic analysis of junction dynamics. This approach helps track the assembly and remodeling of tight junctions in real time.

Overexpression

Overexpression of tight junction proteins like claudins or ZO-1 can enhance barrier function or rescue defects in knockout cells, providing insights into their sufficiency in junction formation. Overexpression models are also used to study the effects of elevated protein levels on cell behavior.

How EDITGENE Supports bicellular tight junction Research

Researchers studying bicellular tight junction-related genes often need to determine whether a candidate gene is causally involved in barrier function, disease progression, or drug response. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for bicellular tight junction research.

Frequently Asked Questions About bicellular tight junction

GO:0005923 is a Gene Ontology term for the bicellular tight junction, also known as the zonula occludens, an occluding cell-cell junction that forms a branching network of sealing strands encircling the apical end of epithelial cells.
Key genes include CLDN1, CLDN2, OCLN, JAM-A, ZO-1, ZO-2, ZO-3, cingulin, and tricellulin, among others.
It acts as a selective barrier that regulates paracellular transport of ions, solutes, and water, and also serves as a signaling platform.
It is regulated by signaling pathways such as AMPK, RhoA, and others that control assembly and permeability.
Tight junction dysfunction is linked to biliary diseases, inflammatory bowel disease, and cancer.
Common methods include TEER, paracellular flux assays, immunofluorescence, electron microscopy, qRT-PCR, and RNA-seq.
CRISPR can generate knockout, point mutation, knock-in, and overexpression models to dissect gene function in barrier biology.
Claudins are transmembrane proteins that form the sealing strands and determine the selectivity of the paracellular barrier.
Yes, butyrate enhances intestinal barrier function by facilitating tight junction assembly via AMPK activation.
Bicellular tight junctions seal the space between two cells, while tricellular tight junctions are specialized structures at points where three cells meet.

Conclusion

The bicellular tight junction (GO:0005923) is a fundamental structure that maintains epithelial barrier function and regulates paracellular transport. Its complex molecular architecture, involving claudins, occludin, JAMs, and scaffolding proteins, is dynamically regulated by signaling pathways and nutrients. Dysregulation of tight junctions contributes to a variety of diseases, making them important targets for therapeutic intervention. Continued research using advanced CRISPR models and imaging techniques will further unravel the mechanisms of tight junction biology and its role in health and disease.

References

  1. 1. Otani T et al.. 2020. Tight Junction Structure and Function Revisited.. Trends Cell Biol 30(10):805-817 PMID: 32891490
  2. 2. Merlen G et al.. 2024. Tight junction proteins and biliary diseases.. Curr Opin Gastroenterol 40(2):70-76 PMID: 38260939
  3. 3. Peng L et al.. 2009. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers.. J Nutr 139(9):1619-25 PMID: 19625695
  4. 4. Zihni C et al.. 2016. Tight junctions: from simple barriers to multifunctional molecular gates.. Nat Rev Mol Cell Biol 17(9):564-80 PMID: 27353478
  5. 5. Krug SM et al.. 2020. Special Issue on "The Tight Junction and Its Proteins: More than Just a Barrier".. Int J Mol Sci 21(13) PMID: 32610530
  6. 6. Brunner J et al.. 2021. Target specific tight junction modulators.. Adv Drug Deliv Rev 171:266-288 PMID: 33617902
  7. 7. Tachibana K et al.. 2024. Heterogenous Gene Expression of Bicellular and Tricellular Tight Junction-Sealing Components in the Human Intestinal Tract.. Biol Pharm Bull 47(6):1209-1217 PMID: 38925921
  8. 8. Suzuki T. 2020. Regulation of the intestinal barrier by nutrients: The role of tight junctions.. Anim Sci J 91(1):e13357 PMID: 32219956
Contact Us
*
*
*
*
How did you hear about us: